Don Weissman, MD

Life Sciences and Healthcare

Strategic Business Development

 Medical Affairs - KOL Governance


  Initiatives, Alliances, Partnerships

 Organizational Effectiveness






Highly accomplished Physician,

Director Medical Affairs and KOL Governance

 Medical Science Liaison and Strategic Development


Outstanding "C level" relationships and success
helping Life Science Companies and Healthcare Institutions 
accelerate product development and optimize market share.



Exceptional education, training and communication skills for
Key Opinion Leader insights, applications, analytics, trials and advocacy.
Advisory Board Development with honored Society and

Board memberships,

and excellent relationships with

 top tier Academic Medical Centers,
Hospitals and Institutions of Excellence. 


Analyst and panel review member for the National Science Foundation,
the National Institute of Health and the Department of Health and

Human Services: biomedical research, diagnostics, genomics
bio-pharmaceuticals, devices and innovative therapeutics.

Adept listener, articulate and persuasive, understanding  
market needs, drivers and implementation. Experienced in 
regulatory affairs,
pharmaco-economics and vigilance for resource
allocation and
Highly successful with the FDA, FTC,
AHRQ and CMS. Proven track record of success for coverage
and reimbursements by major payers, providers and plans.

Honored society, academic and board memberships: strategic CME,
regional and national symposia, peer review publications, brand
and market development with mobile and social media
applications and validation. 


Extraordinary resources, experience and motivational skills building 
professional consensus with renowned academic, research and clinical
leadership and physicians for optimal patient care, outcomes and values.





Innovative therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.


To optimize patient well being and quality of life
with excellence
in clinical, operational and financial outcomes.